Patent · US Active

WT1 HLA class II—binding peptides and compositions and methods comprising same

US9233149B2 · kind B2 · utility

17Cited by
1References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2013
Grant dateJan 12, 2016
Priority date—
Expiry dateSep 16, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/57
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides WT1 peptides and methods of treating, reducing the incidence of, and inducing immune responses against a WT1-expressing cancer, comprising same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.